Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Polyenes
1.2.3 Echinocandins
1.2.4 Azoles
1.2.5 Allylamines
1.2.6 Other Drug types
1.3 Market by Application
1.3.1 Global Antifungal infection Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Dermatology Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antifungal infection Therapeutics Market Perspective (2018-2033)
2.2 Antifungal infection Therapeutics Growth Trends by Region
2.2.1 Global Antifungal infection Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Antifungal infection Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Antifungal infection Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Antifungal infection Therapeutics Market Dynamics
2.3.1 Antifungal infection Therapeutics Industry Trends
2.3.2 Antifungal infection Therapeutics Market Drivers
2.3.3 Antifungal infection Therapeutics Market Challenges
2.3.4 Antifungal infection Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antifungal infection Therapeutics Players by Revenue
3.1.1 Global Top Antifungal infection Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antifungal infection Therapeutics Revenue
3.4 Global Antifungal infection Therapeutics Market Concentration Ratio
3.4.1 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antifungal infection Therapeutics Revenue in 2022
3.5 Antifungal infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Antifungal infection Therapeutics Product Solution and Service
3.7 Date of Enter into Antifungal infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antifungal infection Therapeutics Breakdown Data by Type
4.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2024-2033)
5 Antifungal infection Therapeutics Breakdown Data by Application
5.1 Global Antifungal infection Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Antifungal infection Therapeutics Market Size (2018-2033)
6.2 North America Antifungal infection Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Antifungal infection Therapeutics Market Size by Country (2018-2023)
6.4 North America Antifungal infection Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antifungal infection Therapeutics Market Size (2018-2033)
7.2 Europe Antifungal infection Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Antifungal infection Therapeutics Market Size by Country (2018-2023)
7.4 Europe Antifungal infection Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antifungal infection Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Antifungal infection Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antifungal infection Therapeutics Market Size (2018-2033)
9.2 Latin America Antifungal infection Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Antifungal infection Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Antifungal infection Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antifungal infection Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Antifungal infection Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Scynexis
11.1.1 Scynexis Company Detail
11.1.2 Scynexis Business Overview
11.1.3 Scynexis Antifungal infection Therapeutics Introduction
11.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.1.5 Scynexis Recent Development
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Detail
11.2.2 Sanofi-Aventis Business Overview
11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Introduction
11.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.2.5 Sanofi-Aventis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antifungal infection Therapeutics Introduction
11.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Antifungal infection Therapeutics Introduction
11.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Merck & Co
11.5.1 Merck & Co Company Detail
11.5.2 Merck & Co Business Overview
11.5.3 Merck & Co Antifungal infection Therapeutics Introduction
11.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.5.5 Merck & Co Recent Development
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Detail
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Antifungal infection Therapeutics Introduction
11.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.6.5 Kramer Laboratories Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Antifungal infection Therapeutics Introduction
11.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 ID Sigma-Aldrich Corporation
11.8.1 ID Sigma-Aldrich Corporation Company Detail
11.8.2 ID Sigma-Aldrich Corporation Business Overview
11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Introduction
11.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.8.5 ID Sigma-Aldrich Corporation Recent Development
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Detail
11.9.2 Glenmark Pharmaceuticals Business Overview
11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Introduction
11.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.9.5 Glenmark Pharmaceuticals Recent Development
11.10 Glaxosmithkline
11.10.1 Glaxosmithkline Company Detail
11.10.2 Glaxosmithkline Business Overview
11.10.3 Glaxosmithkline Antifungal infection Therapeutics Introduction
11.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.10.5 Glaxosmithkline Recent Development
11.11 Enzon Pharmaceuticals
11.11.1 Enzon Pharmaceuticals Company Detail
11.11.2 Enzon Pharmaceuticals Business Overview
11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Introduction
11.11.4 Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.11.5 Enzon Pharmaceuticals Recent Development
11.12 Bayer Healthcare
11.12.1 Bayer Healthcare Company Detail
11.12.2 Bayer Healthcare Business Overview
11.12.3 Bayer Healthcare Antifungal infection Therapeutics Introduction
11.12.4 Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.12.5 Bayer Healthcare Recent Development
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Detail
11.13.2 Astellas Pharma Business Overview
11.13.3 Astellas Pharma Antifungal infection Therapeutics Introduction
11.13.4 Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.13.5 Astellas Pharma Recent Development
11.14 Asperqillus
11.14.1 Asperqillus Company Detail
11.14.2 Asperqillus Business Overview
11.14.3 Asperqillus Antifungal infection Therapeutics Introduction
11.14.4 Asperqillus Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.14.5 Asperqillus Recent Development
11.15 Alternaria
11.15.1 Alternaria Company Detail
11.15.2 Alternaria Business Overview
11.15.3 Alternaria Antifungal infection Therapeutics Introduction
11.15.4 Alternaria Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.15.5 Alternaria Recent Development
11.16 Abbott Laboratories
11.16.1 Abbott Laboratories Company Detail
11.16.2 Abbott Laboratories Business Overview
11.16.3 Abbott Laboratories Antifungal infection Therapeutics Introduction
11.16.4 Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023)
11.16.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antifungal infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Polyenes
Table 3. Key Players of Echinocandins
Table 4. Key Players of Azoles
Table 5. Key Players of Allylamines
Table 6. Key Players of Other Drug types
Table 7. Global Antifungal infection Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Antifungal infection Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Antifungal infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Antifungal infection Therapeutics Market Share by Region (2018-2023)
Table 11. Global Antifungal infection Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Antifungal infection Therapeutics Market Share by Region (2024-2033)
Table 13. Antifungal infection Therapeutics Market Trends
Table 14. Antifungal infection Therapeutics Market Drivers
Table 15. Antifungal infection Therapeutics Market Challenges
Table 16. Antifungal infection Therapeutics Market Restraints
Table 17. Global Antifungal infection Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Antifungal infection Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2022)
Table 20. Ranking of Global Top Antifungal infection Therapeutics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Antifungal infection Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antifungal infection Therapeutics Product Solution and Service
Table 24. Date of Enter into Antifungal infection Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Antifungal infection Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Antifungal infection Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Antifungal infection Therapeutics Revenue Market Share by Type (2024-2033)
Table 30. Global Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Antifungal infection Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Antifungal infection Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Antifungal infection Therapeutics Revenue Market Share by Application (2024-2033)
Table 34. North America Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Antifungal infection Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Antifungal infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Scynexis Company Detail
Table 50. Scynexis Business Overview
Table 51. Scynexis Antifungal infection Therapeutics Product
Table 52. Scynexis Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Scynexis Recent Development
Table 54. Sanofi-Aventis Company Detail
Table 55. Sanofi-Aventis Business Overview
Table 56. Sanofi-Aventis Antifungal infection Therapeutics Product
Table 57. Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 58. Sanofi-Aventis Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Antifungal infection Therapeutics Product
Table 62. Pfizer Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Antifungal infection Therapeutics Product
Table 67. Novartis Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Merck & Co Company Detail
Table 70. Merck & Co Business Overview
Table 71. Merck & Co Antifungal infection Therapeutics Product
Table 72. Merck & Co Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 73. Merck & Co Recent Development
Table 74. Kramer Laboratories Company Detail
Table 75. Kramer Laboratories Business Overview
Table 76. Kramer Laboratories Antifungal infection Therapeutics Product
Table 77. Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Kramer Laboratories Recent Development
Table 79. Johnson & Johnson Company Detail
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Antifungal infection Therapeutics Product
Table 82. Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. ID Sigma-Aldrich Corporation Company Detail
Table 85. ID Sigma-Aldrich Corporation Business Overview
Table 86. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product
Table 87. ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 88. ID Sigma-Aldrich Corporation Recent Development
Table 89. Glenmark Pharmaceuticals Company Detail
Table 90. Glenmark Pharmaceuticals Business Overview
Table 91. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product
Table 92. Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 93. Glenmark Pharmaceuticals Recent Development
Table 94. Glaxosmithkline Company Detail
Table 95. Glaxosmithkline Business Overview
Table 96. Glaxosmithkline Antifungal infection Therapeutics Product
Table 97. Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 98. Glaxosmithkline Recent Development
Table 99. Enzon Pharmaceuticals Company Detail
Table 100. Enzon Pharmaceuticals Business Overview
Table 101. Enzon Pharmaceuticals Antifungal infection Therapeutics Product
Table 102. Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 103. Enzon Pharmaceuticals Recent Development
Table 104. Bayer Healthcare Company Detail
Table 105. Bayer Healthcare Business Overview
Table 106. Bayer Healthcare Antifungal infection Therapeutics Product
Table 107. Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Bayer Healthcare Recent Development
Table 109. Astellas Pharma Company Detail
Table 110. Astellas Pharma Business Overview
Table 111. Astellas Pharma Antifungal infection Therapeutics Product
Table 112. Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 113. Astellas Pharma Recent Development
Table 114. Asperqillus Company Detail
Table 115. Asperqillus Business Overview
Table 116. Asperqillus Antifungal infection Therapeutics Product
Table 117. Asperqillus Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 118. Asperqillus Recent Development
Table 119. Alternaria Company Detail
Table 120. Alternaria Business Overview
Table 121. Alternaria Antifungal infection Therapeutics Product
Table 122. Alternaria Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 123. Alternaria Recent Development
Table 124. Abbott Laboratories Company Detail
Table 125. Abbott Laboratories Business Overview
Table 126. Abbott Laboratories Antifungal infection Therapeutics Product
Table 127. Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Abbott Laboratories Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antifungal infection Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Antifungal infection Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Polyenes Features
Figure 4. Echinocandins Features
Figure 5. Azoles Features
Figure 6. Allylamines Features
Figure 7. Other Drug types Features
Figure 8. Global Antifungal infection Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Antifungal infection Therapeutics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Dermatology Clinic Case Studies
Figure 12. Antifungal infection Therapeutics Report Years Considered
Figure 13. Global Antifungal infection Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Antifungal infection Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Antifungal infection Therapeutics Market Share by Region: 2022 VS 2033
Figure 16. Global Antifungal infection Therapeutics Market Share by Players in 2022
Figure 17. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Antifungal infection Therapeutics Revenue in 2022
Figure 19. North America Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 25. Germany Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2018-2033)
Figure 33. China Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 41. Mexico Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 45. Turkey Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Antifungal infection Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Scynexis Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 48. Sanofi-Aventis Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 51. Merck & Co Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 52. Kramer Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 54. ID Sigma-Aldrich Corporation Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 55. Glenmark Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 56. Glaxosmithkline Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 57. Enzon Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 58. Bayer Healthcare Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 59. Astellas Pharma Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 60. Asperqillus Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 61. Alternaria Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 62. Abbott Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed